Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.

Pulse Biosciences, a developer of non-thermal bioelectric treatments, reported a notable insider buy amid recent stock price gains.
Open original source
Pulse Biosciences, a developer of non-thermal bioelectric treatments, reported a notable insider buy amid recent stock price gains.
Open original source